Low-dose aspirin linked to lower cardiovascular event risk for adults with Type 2 diabetes: Study Written By Dr. Kamal Kant Kohli22 Dec 2025 8:30 PM ISTPeople with Type 2 diabetes (T2D) and an elevated risk for cardiovascular disease (CVD) who took low-dose aspirin were less likely to experience a...
Tirzepatide Matches Dulaglutide for Cardiovascular Protection With Added Metabolic Benefits: NEJM Written By Dr Riya Dave22 Dec 2025 11:00 AM ISTIn a large randomized trial involving patients with type 2 diabetes and established atherosclerotic cardiovascular disease, tirzepatide was...
Bayer Finerenone approved in Japan for chronic heart failure Written By Ruchika Sharma22 Dec 2025 10:30 AM ISTBerlin: Bayer has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for finerenone (Kerendia), a non-steroidal, selective...
FDA Approves Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy Written By Dr. Kamal Kant Kohli22 Dec 2025 10:30 AM ISTThe US Food and Drug Administration has approved aficamten (Myqorzo), an allosteric cardiac myosin inhibitor, for adults with symptomatic obstructive...
Dark-Field X-Ray Speeds Up Pneumothorax Detection Without Losing Accuracy: Study Shows Written By Medha Baranwal21 Dec 2025 8:45 PM ISTGermany: Adding dark-field radiography to standard chest X-rays may significantly improve the detection of pneumothorax while markedly shortening...
Abbott gets USFDA clearance for Amplatzer Piccolo Delivery System for premature babies with heart hole Written By Ruchika Sharma21 Dec 2025 3:15 PM ISTAbbott Park: Abbott has announced it has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its Amplatzer Piccolo...
ART Cycles Linked to Slight Increase in Cardiovascular Risk, Suggests Research Written By Medha Baranwal20 Dec 2025 9:15 AM ISTNorway: Researchers have found in a new registry-based study that each additional cycle of assisted reproductive technology was associated with a...
Dapagliflozin vs Empagliflozin Show Similar Clinical Outcomes in HF: JAMA Written By Dr Riya Dave20 Dec 2025 8:45 AM ISTA cohort study in patients with heart failure (HF) found that dapagliflozin and empagliflozin provided comparable clinical outcomes. The authors note...
What are Key Predictors of Bleeding Risk with Long-Term Apixaban in Cancer-Associated VTE? Written By Dr Riya Dave20 Dec 2025 6:45 AM ISTAccording to a new study, among patients receiving extended anticoagulation with apixaban for cancer-associated VTE, four predictors of clinically...
GLP-1 Receptor Agonists Linked to Lower All-Cause Mortality in Hypertrophic Cardiomyopathy: AHJ, December 2025 Study Reveals New Cardiovascular Benefits Written By Prem Aggarwal19 Dec 2025 10:30 AM ISTA recent study found that Glucagon-like peptide-1 (GLP-1) receptor agonist use in hypertrophic cardiomyopathy (HCM) patients with type 2 diabetes...
Lowering blood sugar cuts heart attack risk in people with prediabetes: Lancet Written By Dr. Kamal Kant Kohli19 Dec 2025 10:00 AM ISTLowering blood sugar levels halves the likelihood of serious heart problems in people with prediabetes. According to King's College London research,...
TyG Index Strongly Predicts Subclinical Myocardial Injury, Especially in Diabetes: Study Written By Jacinthlyn Sylvia19 Dec 2025 9:15 AM ISTA new study published in the journal of Cardiovascular Diabetology showed that for the first time, a U-shaped correlation was found between the...
